Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.

Briody S, Boules M, Oliveros A, Fauq I, Richelson E.

Behav Brain Res. 2010 Feb 11;207(1):118-24. doi: 10.1016/j.bbr.2009.09.044. Epub 2009 Oct 2.

2.

The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.

Secchi RL, Sung E, Hedley LR, Button D, Schreiber R.

Behav Brain Res. 2009 Sep 14;202(2):192-7. doi: 10.1016/j.bbr.2009.03.034. Epub 2009 Apr 1.

PMID:
19463701
3.

Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.

Oliveros A, Heckman MG, Del Pilar Corena-McLeod M, Williams K, Boules M, Richelson E.

J Exp Biol. 2010 Dec 15;213(Pt 24):4232-9. doi: 10.1242/jeb.046318.

4.

The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.

Shilling PD, Richelson E, Feifel D.

Behav Brain Res. 2003 Jul 14;143(1):7-14.

PMID:
12842291
5.

Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.

Shilling PD, Melendez G, Priebe K, Richelson E, Feifel D.

Psychopharmacology (Berl). 2004 Sep;175(3):353-9.

PMID:
15107967
6.

Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.

Boules M, McMahon B, Wang R, Warrington L, Stewart J, Yerbury S, Fauq A, McCormick D, Richelson E.

Brain Res. 2003 Oct 10;987(1):39-48.

PMID:
14499944
7.

Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.

Feifel D, Priebe K, Johnstone-Miller E, Morgan CJ.

Psychopharmacology (Berl). 2002 Jul;162(2):138-46. Epub 2002 May 9.

PMID:
12110991
8.

Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.

Cusack B, Boules M, Tyler BM, Fauq A, McCormick DJ, Richelson E.

Brain Res. 2000 Feb 21;856(1-2):48-54.

PMID:
10677610
9.

Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.

Nakaya K, Nakagawasai O, Arai Y, Onogi H, Sato A, Niijima F, Tan-No K, Tadano T.

Behav Brain Res. 2011 Mar 17;218(1):165-73. doi: 10.1016/j.bbr.2010.11.053. Epub 2010 Dec 3.

PMID:
21130810
10.

Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.

Kinkead B, Dobner PR, Egnatashvili V, Murray T, Deitemeyer N, Nemeroff CB.

J Pharmacol Exp Ther. 2005 Oct;315(1):256-64. Epub 2005 Jun 29.

11.

The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.

Li Z, Boules M, Williams K, Peris J, Richelson E.

Brain Res. 2010 Jan 22;1311:28-36. doi: 10.1016/j.brainres.2009.11.048. Epub 2009 Nov 27.

12.

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.

Fredrickson P, Boules M, Yerbury S, Richelson E.

Eur J Pharmacol. 2003 Jan 1;458(1-2):111-8.

PMID:
12498914
13.

Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats.

Bortolato M, Frau R, Orrù M, Collu M, Mereu G, Carta M, Fadda F, Stancampiano R.

Psychopharmacology (Berl). 2008 Jun;198(2):191-200. doi: 10.1007/s00213-008-1116-9. Epub 2008 Mar 12.

PMID:
18330544
14.

Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats.

Wadenberg MG, Sills TL, Fletcher PJ, Kapur S.

Biol Psychiatry. 2000 Apr 1;47(7):670-6.

PMID:
10745061
15.

Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.

Hertel P, Byskov L, Didriksen M, Arnt J.

Eur J Pharmacol. 2001 Jun 22;422(1-3):77-81.

PMID:
11430916
16.

Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.

Zhang M, Ballard ME, Unger LV, Haupt A, Gross G, Decker MW, Drescher KU, Rueter LE.

Behav Brain Res. 2007 Aug 22;182(1):1-11. Epub 2007 May 1.

PMID:
17570538
17.

Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.

Levin R, Calzavara MB, Santos CM, Medrano WA, Niigaki ST, Abílio VC.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1748-52. doi: 10.1016/j.pnpbp.2011.06.003. Epub 2011 Jun 13.

18.

NT79: A novel neurotensin analog with selective behavioral effects.

Boules M, Liang Y, Briody S, Miura T, Fauq I, Oliveros A, Wilson M, Khaniyev S, Williams K, Li Z, Qi Y, Katovich M, Richelson E.

Brain Res. 2010 Jan 13;1308:35-46. doi: 10.1016/j.brainres.2009.10.050. Epub 2009 Oct 27.

19.

Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.

Linn GS, Negi SS, Gerum SV, Javitt DC.

Psychopharmacology (Berl). 2003 Sep;169(3-4):234-9. Epub 2003 Jul 4.

PMID:
12845408
20.

Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.

Chou S, Davis C, Jones S, Li M.

Pharmacol Biochem Behav. 2015 Jan;128:78-88. doi: 10.1016/j.pbb.2014.11.015. Epub 2014 Nov 26.

Items per page

Supplemental Content

Write to the Help Desk